Budapest, Hungary

Dénes Kónya

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Pharmahungary 2000 Kft., Targetex Kft.. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dénes Kónya. Retrieved from https://idiyas.com/inventor/dénes-kónya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 14.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dénes Kónya: Innovator in Pharmaceutical Chemistry

Introduction

Dénes Kónya is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of inhibitors for matrix metalloproteinases. His work has implications for various medical applications, showcasing his expertise and innovative spirit.

Latest Patents

Dénes Kónya holds a patent for "Inhibitors of matrix metalloproteinases - Compounds of general formula (I), salts or solvates thereof and pharmaceutical compositions containing same." This patent highlights his focus on creating compounds that can potentially lead to advancements in therapeutic treatments.

Career Highlights

Throughout his career, Kónya has worked with several companies, including Pharmahungary 2000 Kft. and Targetex Kft. His experience in these organizations has allowed him to apply his knowledge and skills in practical settings, contributing to the development of innovative pharmaceutical solutions.

Collaborations

Dénes Kónya has collaborated with notable professionals in his field, including Péter Ferdinandy and Tamás Bálint Csont. These partnerships have enriched his research and development efforts, fostering a collaborative environment for innovation.

Conclusion

Dénes Kónya's contributions to pharmaceutical chemistry and his innovative patents underscore his role as a significant inventor in the industry. His work continues to influence the development of new therapeutic compounds, reflecting his dedication to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…